198 related articles for article (PubMed ID: 14688363)
1. IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization.
Ha SJ; Kim DJ; Baek KH; Yun YD; Sung YC
J Immunol; 2004 Jan; 172(1):525-31. PubMed ID: 14688363
[TBL] [Abstract][Full Text] [Related]
2. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
3. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
[TBL] [Abstract][Full Text] [Related]
4. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
[TBL] [Abstract][Full Text] [Related]
5. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
Takamura S; Matsuo K; Takebe Y; Yasutomi Y
J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
[TBL] [Abstract][Full Text] [Related]
6. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
Li P; Wan Q; Feng Y; Liu M; Wu J; Chen X; Zhang XL
Vaccine; 2007 Feb; 25(8):1544-51. PubMed ID: 17055129
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.
Matsui M; Moriya O; Belladonna ML; Kamiya S; Lemonnier FA; Yoshimoto T; Akatsuka T
J Virol; 2004 Sep; 78(17):9093-104. PubMed ID: 15308705
[TBL] [Abstract][Full Text] [Related]
8. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
9. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.
Xin KQ; Hamajima K; Sasaki S; Tsuji T; Watabe S; Okada E; Okuda K
Vaccine; 1999 Feb; 17(7-8):858-66. PubMed ID: 10067692
[TBL] [Abstract][Full Text] [Related]
10. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
[TBL] [Abstract][Full Text] [Related]
11. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
12. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
13. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.
Kopp T; Lenz P; Bello-Fernandez C; Kastelein RA; Kupper TS; Stingl G
J Immunol; 2003 Jun; 170(11):5438-44. PubMed ID: 12759419
[TBL] [Abstract][Full Text] [Related]
14. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
15. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
[TBL] [Abstract][Full Text] [Related]
16. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
Shimozato O; Ugai S; Chiyo M; Takenobu H; Nagakawa H; Wada A; Kawamura K; Yamamoto H; Tagawa M
Immunology; 2006 Jan; 117(1):22-8. PubMed ID: 16423037
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice.
Song MK; Lee SW; Suh YS; Lee KJ; Sung YC
J Virol; 2000 Mar; 74(6):2920-5. PubMed ID: 10684312
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
19. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
Rice J; Buchan S; Stevenson FK
J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag.
Sun W; Li Q; Zhu D; Feng J; Zhuang Z; Sun X; Xiao G; Duan Y
J Med Virol; 2015 Dec; 87(12):2090-7. PubMed ID: 26010499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
